346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

1995 ◽  
Vol 31 ◽  
pp. S75 ◽  
Author(s):  
R. Paridaens ◽  
P. Bruning ◽  
F. Calabresi ◽  
A. Awada ◽  
J.A. Roy ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
First Line ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer

2007 ◽  
Vol 13 (12) ◽  
pp. 3652-3659 ◽  
Author(s):  
Antonio Llombart-Cussac ◽  
Miguel Martin ◽  
Nadia Harbeck ◽  
Rodica M. Anghel ◽  
Alexandra E. Eniu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
First Line ◽  
Double Blind ◽  
Line Chemotherapy

Paclitaxel and Gemcitabine, As First-Line Chemotherapy, Combined with Trastuzumab in Patients with Advanced Breast Cancer: A Phase II Study Conducted by the Hellenic Cooperative Oncology Group (HeCOG)

2004 ◽  
Vol 22 (5) ◽  
pp. 655-662 ◽  
Author(s):  
George Fountzilas ◽  
Christos Christodoulou ◽  
Dimitrios Tsavdaridis ◽  
Anna Kalogera-Fountzila ◽  
Gerassimos Aravantinos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Oncology Group ◽  
First Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document